Logo

Heiner Dreismann and Charles Woler

Feb 19, 2016

NovellusDx has appointed Heiner Dreismann and Charles Woler to its board of directors. Dreismann currently serves on the boards of several public and private healthcare companies. Previously, he held several senior positions with Roche Group, including president and CEO of Roche Molecular Systems and head of global business development for Roche Diagnostics. Woler previously served as CEO of Roche France, CEO of SmithKline Beecham's European pharmaceutical business, CEO of Cadus Pharmaceuticals, CEO of Neruo3d and Endotis Pharma, and recently Biomnis.

Breaking News
The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.